Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen for GERD in Children With Cerebral Palsy
NCT01386255Phase 4Withdrawn
- Sponsor
- Boston Children's Hospital
- Start
- Apr 2009
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of baclofen in gastroesophageal reflux disease (GERD), sponsored by Boston Children's Hospital. Planned start Apr 2009; status: withdrawn.
02
Drugs
baclofen
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01386255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01386255.